Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mankind Pharma Ltd
MANKIND | NSE
2,226.40
INR19.20
0.87%
MANKIND | NSE
About Mankind Pharma Ltd
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/03/2026
Close
2,226.40
Open
2,210.80
High
2,239.80
Low
2,191.60
Mankind Pharma Limited develops manufactures and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective cardiovascular gastrointestinal anti-diabetic neuro/CNS vitamins/minerals/nutrients and respiratory diseases. It also offers consumer healthcare products such as condoms pregnancy detection kits emergency contraceptives antacid powders vitamin and mineral supplements and antiacne preparations. The company offers its products primarily under the Manforce Prega News Unwanted-72 Gas-O-Fas Health OK and AcneStar brand names. In addition it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials and consumer goods; real estate leasing and hospitality businesses; and provision of IT services. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi India.
View LessMANKIND | NSE
Risk
35.6
Sharpe
-0.35
Luna's Score
60/100
Recommendation
Hold
Luna says (MANKIND | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
41.8%1 month
35.6%3 months
29.4%6 months
23.8%Returns
Fundamental Ratios
PE
54.23
Fwd. PE
-
Price to book
11.60
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
36.44
Ent. to rev.
9.90
PEG
-
Other Fundamentals
EBITDA
25.60B
MarketCap
891.99B
MarketCap(USD)
9.71B
Div. yield
-
Op. margin
19.84
Erngs. growth
10.10
Rev. growth
12.20
Ret. on equity
22.58
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
272.60
Range1M
272.60
Range3M
308.60
Volumes: Market Activity
Rel. volume
0.60
Price X volume
695.27M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 36.44 | 24.85 | Expensive |
| Ent. to Revenue | 9.90 | 11.40 | Par |
| PE Ratio | 54.23 | 51.36 | Par |
| Price to Book | 11.60 | 6.83 | Expensive |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 29.36 | 42.17 | Lower Risk |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.02 | 0.17 | Cheaper |
| Market Cap | 891.99B | 290.82B | Market Leader |
